Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response

Introduction: Belatacept is a common immunosuppressive therapy used after kidney transplantation (KT) to avoid calcineurin-inhibitor (CNI) use and its related toxicities. It is unclear whether its use exposes KT recipients (KTx) to a greater risk of infection or a poorer response to vaccines. Areas...

Descripción completa

Detalles Bibliográficos
Autores principales: Terrec, Florian, Jouve, Thomas, Malvezzi, Paolo, Janbon, Bénédicte, Naciri Bennani, Hamza, Rostaing, Lionel, Noble, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585113/
https://www.ncbi.nlm.nih.gov/pubmed/34768680
http://dx.doi.org/10.3390/jcm10215159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585113/
https://www.ncbi.nlm.nih.gov/pubmed/34768680
http://dx.doi.org/10.3390/jcm10215159

Ejemplares similares